Following a full submission
AWMSG advice |
|||
| Status: Recommended | |||
Levonorgestrel (Jaydess®) is recommended as an option for use within NHS Wales for contraception for up to three years. |
|||
|
|||
Medicine details |
|||
| Medicine name | levonorgestrel (Jaydess®) | ||
| Formulation | 13.5 mg intrauterine device | ||
| Reference number | 1158 | ||
| Indication | Contraception for up to 3 years |
||
| Company | Bayer Healthcare Pharmaceuticals | ||
| BNF chapter | Obstetrics, gynaecology & urinary tract disorders | ||
| Assessment type | Full | ||
| Status | Recommended | ||
| Advice number | 1515 | ||
| NMG meeting date | 13/05/2015 | ||
| AWMSG meeting date | 17/06/2015 | ||
| Ratification by Welsh Government | 15/07/2015 | ||
| Date of issue | 16/07/2015 | ||
| Date of last review | 10/04/2018 | ||